MDCX
Medicus Pharma·NASDAQ
--
--(--)
--
--(--)
10.18 / 10
Outperform
Analyst consensus is overwhelmingly bullish: 100% Strong Buy from two recommendations. Sentiment score is 10.18, and fund‑flow score 7.53 indicates strong positive inflows across all investor sizes, supporting a favorable market outlook.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-19
InstitutionD. Boral Capital
Times predicted22
Historical Win Rate40.9%
Is money flowing into or out of MDCX?
- MDCX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 10.18/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
